Citigroup »

Abeona Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Abeona Therapeutics (ABEO) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Abeona Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Abeona Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abeona Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.3M 450k 5.01
2023-09-30 $1.9M 450k 4.21

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf (EEM)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Broadcom (AVGO)

View all positions for Citigroup

Top funds holding Abeona Therapeutics

Nantahala Capital Management
Millennium Management
Vanguard Group
Western Standard
AIGH Capital Management
Point72 Asset Management
Ikarian Capital
Citigroup
J. Goldman & Co
Worth Venture Partners
Walleye Trading Advisors
Barclays
Bank of New York Mellon
Citadel Advisors
Alyeska Investment Group

View all funds holding Abeona Therapeutics